Fresh biopsy tech aims to crack Cancer's code, match patients to best drugs
NCT ID NCT07431073
Summary
This trial aims to improve cancer treatment by using a rapid, detailed analysis of a patient's fresh tumor and blood to guide therapy. It will enroll 275 people with advanced solid tumors to test if matching patients to specific immunotherapies based on their unique biology leads to better outcomes. The goal is to move beyond a one-size-fits-all approach to create more personalized and effective cancer care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED/METASTATIC SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.